Free Trial

Caribou Biosciences (CRBU) SEC Filings & 10K Form

Caribou Biosciences logo
$1.43 +0.12 (+9.16%)
Closing price 01/31/2025 04:00 PM Eastern
Extended Trading
$1.47 +0.04 (+2.80%)
As of 01/31/2025 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Caribou Biosciences SEC Filings

DateFilerForm TypeView
01/13/2025
7:00 AM
Caribou Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
4:06 PM
Caribou Biosciences (Issuer)
Ryali Sriram (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
3:55 PM
Caribou Biosciences (Issuer)
Ryali Sriram (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2025
7:03 AM
Caribou Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
6:53 PM
Caribou Biosciences (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G/A
11/14/2024
5:08 PM
Avidity Partners Management LP (Filed by)
Caribou Biosciences (Subject)
Form SC 13G/A
11/14/2024
3:03 PM
Caribou Biosciences (Subject)
PFM Health Sciences, LP (Filed by)
Form SC 13G/A
11/06/2024
3:07 PM
Caribou Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
3:08 PM
Caribou Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2024
10:21 AM
Caribou Biosciences (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/17/2024
11:12 AM
Caribou Biosciences (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
10/04/2024
3:02 PM
Caribou Biosciences (Issuer)
Fischesser Ryan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/27/2024
3:02 PM
Caribou Biosciences (Filer)
Form 8-K/A
08/12/2024
7:03 AM
Caribou Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2024
5:01 AM
Caribou Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2024
3:05 PM
Caribou Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2024
4:08 PM
Caribou Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/11/2024
3:22 PM
Caribou Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/23/2024
3:15 PM
Caribou Biosciences (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G
02/22/2024
4:28 PM
Caribou Biosciences (Issuer)
O'Byrne Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
4:12 PM
Caribou Biosciences (Issuer)
Zheng Ran (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
4:15 PM
Caribou Biosciences (Issuer)
Kanner Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
4:18 PM
Caribou Biosciences (Issuer)
Haurwitz Rachel E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
4:21 PM
Caribou Biosciences (Issuer)
Khan Ruhi Ahmad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
4:24 PM
Caribou Biosciences (Issuer)
MCCLUNG BARBARA G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
5:30 AM
Caribou Biosciences (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G/A
02/08/2024
4:06 PM
Caribou Biosciences (Issuer)
Kanner Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CRBU) was last updated on 2/1/2025 by MarketBeat.com Staff
From Our Partners